novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

A new concept in the treatment of HF: a complementary and synergistic approach to heart efficiency – Maurizio Volterrani

13 Setembro 2017

Resumo da apresentação

Apresentação

Maurizio Volterrani
IT

ESC Congress 2017 - Barcelona - Estudos Clínicos

11 Setembro 2017
0

Chronic stable angina beyond revascularization - Lopez Sendon

20 Setembro 2017
0

-->